Forian Inc
NASDAQ:FORA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.02
3.69
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one FORA stock under the Base Case scenario is 2.145 USD. Compared to the current market price of 2.055 USD, Forian Inc is Undervalued by 4%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Forian Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for FORA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Forian Inc
Balance Sheet Decomposition
Forian Inc
Current Assets | 56.4m |
Cash & Short-Term Investments | 48m |
Receivables | 4.6m |
Other Current Assets | 3.8m |
Non-Current Assets | 1.9m |
PP&E | 106.2k |
Other Non-Current Assets | 1.8m |
Current Liabilities | 8m |
Accounts Payable | 1.5m |
Accrued Liabilities | 3.3m |
Other Current Liabilities | 3.2m |
Non-Current Liabilities | 24.7m |
Long-Term Debt | 24.2m |
Other Non-Current Liabilities | 524k |
Earnings Waterfall
Forian Inc
Revenue
|
20.4m
USD
|
Cost of Revenue
|
-6.5m
USD
|
Gross Profit
|
13.9m
USD
|
Operating Expenses
|
-19.4m
USD
|
Operating Income
|
-5.5m
USD
|
Other Expenses
|
7.5m
USD
|
Net Income
|
2m
USD
|
Free Cash Flow Analysis
Forian Inc
USD | |
Free Cash Flow | USD |
FORA Profitability Score
Profitability Due Diligence
Forian Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Forian Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
FORA Solvency Score
Solvency Due Diligence
Forian Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Forian Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FORA Price Targets Summary
Forian Inc
According to Wall Street analysts, the average 1-year price target for FORA is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
Dividends
Current shareholder yield for FORA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 138 full-time employees. The company went IPO on 2021-03-03. The firm provides software solutions, data and predictive analytics to optimize the operational, clinical and financial performance of its healthcare, cannabis, and government customers. Its BioTrack vertically integrated point-of-sale, manufacturing, delivery and cultivator software solution is a commercial platform in the cannabis industry, serving dispensaries, cultivators, manufacturers and distributors within 38 states and Puerto Rico. Its Cannalytics software as a service (SaaS)-based analytics solution is a platform that provides clients with a configurable and flexible presentation of business performance. Its real world experience (RWE) solutions are designed to enable the integration otherwise unconnected and disparate data to enable near real-time surveillance of adverse events and to study the clinical economic and social impacts of various therapeutic alternatives, including those derived from cannabinoids and psychedelics.
Contact
IPO
Employees
Officers
The intrinsic value of one FORA stock under the Base Case scenario is 2.145 USD.
Compared to the current market price of 2.055 USD, Forian Inc is Undervalued by 4%.